Prospective SPINE Registry (SPINE)

March 8, 2024 updated by: Xtant Medical

Prospective Study on Safety and Performance of Surgalign spINE Products

This study is a prospective, multi-center, open label registry designed to collect real-world data on performance and safety data on RTI's spine products.

Study Overview

Study Type

Observational

Enrollment (Estimated)

5000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Ganderkesee, Germany, 27777
        • Withdrawn
        • STENUM Ortho Fachklinik
      • Gelnhausen, Germany, 63571
        • Active, not recruiting
        • Wirbelsäulenzentrum Fulda | Main | Kinzig
      • Koblenz, Germany, D-56073
        • Withdrawn
        • Katholisches Klinikum Koblenz - Montabaur
      • Werne, Germany, 59368
        • Withdrawn
        • St. Christopherus Krankenhaus - Katholisches Klinikum
      • Toledo, Spain, 45004
        • Recruiting
        • Hospital Nacional de Parapléjicos
        • Contact:
          • María Elena Alonso
          • Phone Number: 34 925 24 77 00
    • Connecticut
      • Hartford, Connecticut, United States, 06102
        • Active, not recruiting
        • Hartford Hospital
    • Florida
      • Boca Raton, Florida, United States, 33496
        • Active, not recruiting
        • Florida Back Institute
      • Delray Beach, Florida, United States, 33484
        • Active, not recruiting
        • Spine Institute of South Florida
    • Illinois
      • Bartlett, Illinois, United States, 60103
        • Terminated
        • Suburban Orthopaedics
    • Indiana
      • Carmel, Indiana, United States, 46032
        • Withdrawn
        • Indiana Spine Group
      • Crown Point, Indiana, United States, 46307
        • Completed
        • DK Orthopedics
    • Ohio
      • Cincinnati, Ohio, United States, 45219
        • Active, not recruiting
        • Lindner Center for Research & Education at The Christ Hospit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients that have spinal problems requiring treatment with an RTI Surgical spine product.

Description

Inclusion Criteria:

  1. Candidate for RTI spine product.
  2. Willing and able to consent to the study.

Exclusion Criteria:

  1. Patient who is, or is expected to be inaccessible for follow-up.
  2. Patient meets any exclusion criteria required by local law (e.g. age, mental capacity, etc.).
  3. Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligible for the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention Rates
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Rates of reoperation and/or revision procedures at index level
1 month, 3 months, 6 months, 12 months, and 24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Fusion success measures by radiological assessment (x-ray, CT scan, MRI, etc.)
1 month, 3 months, 6 months, 12 months, and 24 months
Radiographic Findings
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Change in radiographic findings
1 month, 3 months, 6 months, 12 months, and 24 months
Adverse Events
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Number of procedure and device related adverse events
1 month, 3 months, 6 months, 12 months, and 24 months
Disability (Cervical)
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Change in Neck Disability Index
1 month, 3 months, 6 months, 12 months, and 24 months
Disability (non-Cervical)
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Change in Oswestry Disability Index
1 month, 3 months, 6 months, 12 months, and 24 months
Pain Change
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Change in pain as determined by Visual Analogue Scale (VAS)
1 month, 3 months, 6 months, 12 months, and 24 months
Time to Intervention
Time Frame: 1 month, 3 months, 6 months, 12 months, and 24 months
Time to first reoperation and/or revision procedure at index leve
1 month, 3 months, 6 months, 12 months, and 24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2020

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

November 20, 2019

First Submitted That Met QC Criteria

November 21, 2019

First Posted (Actual)

November 25, 2019

Study Record Updates

Last Update Posted (Actual)

March 12, 2024

Last Update Submitted That Met QC Criteria

March 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 19094

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share IPD

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Joint Diseases

Clinical Trials on RTI Spine products

3
Subscribe